GlassScriptPhysician profile
William P Long
NPI 1568430460
$1,212.01
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $135 · 2021: $542 · 2022: $195 · 2023: $57.87 · 2024: $54.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $353.34 | 2021 | |
| Abbvie INC. | $261.58 | 2019-2023 | |
| Astellas Pharma US INC | $130.05 | 2019-2023 | Veozah |
| Pfizer INC. | $109.12 | 2020-2024 | |
| Myovant Sciences INC. | $98.93 | 2021-2022 | |
| Therapeuticsmd, INC. | $67.97 | 2019-2021 | |
| Hologic Sales and Service, LLC | $51.01 | 2019-2024 | Coolseal Generator, Aptima |
| Allergan, INC. | $23.21 | 2019 | |
| Davol INC. | $21.52 | 2021 | |
| Sumitomo Pharma America, INC. | $19.85 | 2024 | Myfembree |
| Boston Scientific Corporation | $16.49 | 2019 | |
| Organon LLC | $16.31 | 2022 | |
| Dysis Medical, INC. | $15.63 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.44 | 2019 | |
| Aspira Women'S Health INC | $12.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.